The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Cognitive Dysfunction and Diabetes Mellitus
Open accessAbstract
The deleterious effects of diabetes mellitus on the retinal, renal, cardiovascular, and peripheral nervous systems are widely acknowledged.Less attention has been given to the effect of diabetes on cognitive function.Both type 1 and type 2 diabetes mellitus have been associated with reduced performance on numerous domains of cognitive function.The exact pathophysiology of cognitive dysfunction in diabetes is not completely understood, but it is likely that hyperglycemia, vascular disease, hypoglycemia, and insulin resistance play significant roles.Modalities to study the effect of diabetes on the brain have evolved over the years, including neurocognitive testing, evoked response potentials, and magnetic resonance imaging.Although much insightful research has examined cognitive dysfunction in patients with diabetes, more needs to be understood about the mechanisms and natural history of this complication in order to develop strategies for prevention and treatment.(Endocrine Reviews 29: 494 -511, 2008) I. Introduction II.Cognitive Dysfunction in Patients with Diabetes A. Type 1 diabetes B. Type 2 diabetes C. Hypoglycemia and cognitive dysfunction D. Section summary III.Pathophysiology of Cognitive Dysfunction in Diabetes A. The role of hyperglycemia B. The role of vascular disease C. The role of hypoglycemia D. The role of insulin resistance and amyloid IV.Modalities for Assessment of Cognitive Dysfunction in Patients with Diabetes V. Future Directions VI.Conclusion I. Introduction D IABETES MELLITUS IS a complex metabolic diseasethat can have devastating effects on multiple organs in the body.Diabetes is the leading cause of end stage renal disease in the United States (1) and is also a common cause of vision loss, neuropathy, and cardiovascular disease.A less addressed and not as well recognized complication of diabetes is cognitive dysfunction.Patients with type 1 and type 2 diabetes mellitus have been found to have cognitive deficits that can be attributed to their disease.Both hypoglycemia and hyperglycemia have been implicated as causes of cog-nitive dysfunction, and many patients fear that recurrent hypoglycemia will impair their memory over time.Although much research has been done, the pathophysiology underlying this complication is not well understood, and the most appropriate methods to diagnose, treat, and prevent cognitive dysfunction in diabetes have not yet been defined.In this article, we will review the nature of cognitive dysfunction in type 1 and type 2 diabetes mellitus, the pathophysiology of cognitive dysfunction secondary to diabetes, methodologies used to assess cognitive deficits in patients with diabetes, and potential future directions of research that are needed to advance our understanding of this often overlooked complication of diabetes.The purpose of this article is to present a comprehensive review of the literature regarding the subject of cognitive dysfunction in diabetes mellitus.To do this, we performed MEDLINE searches for such key words and terms as "diabetes mellitus," "cognitive function," "cognition," "hypoglycemia," "insulin resistance," and "Alzheimer's disease," among others.We then pursued articles referenced in these sources.Although this is a comprehensive review, it is not exhaustive.In addition, it should be noted that the field of cognitive dysfunction in diabetes is still in its early stages.It must be remembered that although there have been many significant contributions regarding the association of diabetes and cognitive dysfunction and many hypotheses based on this association, the causative mechanisms of diabetes on cognitive dysfunction are still undergoing development. II. Cognitive Dysfunction in Patients with Diabetes A. Type 1 diabetesCognitive dysfunction in patients with diabetes mellitus was first noted in 1922, when patients with diabetes, who were "free from acidosis but usually not sugar free," were noted to have impaired memory and attention on cognitive testing compared with controls (2).Since then, there have been many studies designed to better delineate the scope and First Published Online April 24,
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Cited by
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Systemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies
Gudala, K., Bansal, D., Schifano, F., & Bhansali, A. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12087 · Cited by 727
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Srikanth, V., Maczurek, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., & Münch, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.016 · Cited by 524
Metadata
- Authors
- Kodl, C. T., & Seaquist, E. R.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-04-24
- Volume
- 29
- Issue
- 4
- Pages
- 494-511
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2050970964
- Cited by
- 802
- References
- 219
- FWCI
- 19.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cognitive Dysfunction and Diabetes Mellitus. https://app.cochat.ai/papers/10.1210/er.2007-0034
- The paper
- Kodl, C. T., & Seaquist, E. R. (2008). Cognitive Dysfunction and Diabetes Mellitus. Endocrine Reviews. https://doi.org/10.1210/er.2007-0034
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.